GLP-1 creator claims fact-checked: what TikTok gets wrong

What did @iamlmichelle actually say?

Honestly? Not much that's fact-checkable. The transcript here is garbled audio or a corrupted caption, repeating fragments like "I'm gonna be the fan of my new friends" three times over. There are no specific health claims, no dosing advice, no drug comparisons, and no medical assertions of any kind to analyze.

This happens more often than you'd think on TikTok. Auto-transcription fails, audio gets clipped, or a video's actual content simply doesn't make it into the caption system cleanly. What we're left with is a looped phrase that sounds like the beginning of a personal intro or a lifestyle post, nothing more.

Without a coherent transcript, any fact-check would be fabricated. We're not going to invent claims and then debunk them. That would be worse journalism than the original video.

Does the science back this up?

There's nothing to test against the science here. No claim was made. That said, since this video is tagged under the GLP-1 category, it's worth using this space to address what actually circulates in this content niche, because there's plenty that needs scrutiny.

GLP-1 receptor agonists like semaglutide and tirzepatide are among the most studied weight-loss drugs in recent history. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide producing up to 22.5% mean body weight reduction over 72 weeks. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4 mg producing roughly 14.9% weight reduction. These are real, peer-reviewed results from large randomized controlled trials. But they come with real side effect profiles too, including nausea, vomiting, and the more serious risk of pancreatitis in susceptible individuals.

What did they get wrong (or right)?

Neither applies here. There is no coherent claim to evaluate. That might actually be the most responsible outcome in a content category where misinformation runs rampant. GLP-1 TikTok is full of creators overpromising results, casually recommending doses, and blurring the line between compounded peptides and FDA-approved brand-name drugs. A video that says nothing is, in this case, doing less harm than most.

What we can say plainly: the GLP-1 space on social media has a serious accuracy problem. A 2023 analysis of health content on TikTok found that a significant proportion of videos about prescription weight-loss drugs contained misleading claims about efficacy or safety. Creators with 17,000 views have real influence on real patients who may be making medication decisions based on what they watch at 11pm.

What should you actually know?

If you found this video through a search for GLP-1 information, here's what the actual evidence says. Semaglutide and tirzepatide are FDA-approved medications that require a prescription and medical supervision. Compounded versions of these drugs are not the same product as the brand-name versions and should never be presented as equivalent. The FDA has issued multiple warnings about compounded semaglutide quality and labeling issues.

Side effects are real and range from mild gastrointestinal discomfort to more serious risks including gastroparesis and thyroid concerns flagged in animal studies. Anyone starting or stopping these medications should do so under the guidance of a licensed clinician who knows their full medical history, not based on a TikTok video, including this one. If a creator is telling you what dose to take or claiming their peptide protocol cured their insulin resistance, that's a red flag worth taking seriously.